Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
WILMETTE, Ill., Feb. 22, 2024 -- Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced promising...
Monopartx Linkedin Kimr Tsuchimoto Andrew Cittadine Exchange Commission Human Research Ethics Committee Monopar Therapeutics Inc
Source: marketscreener.com